This topic contains a solution. Click here to go to the answer

Author Question: Management by exception-active is a. A form of transformational leadership b. The non-leadership ... (Read 90 times)

audragclark

  • Hero Member
  • *****
  • Posts: 579
Management by exception-active is
 
  a. A form of transformational leadership
  b. The non-leadership factor
  c. A form of transactional leadership
  d. More effective than contingent reward

Question 2

Our team has just the right mix of people with complementary skills and strengths. Our team is displaying which characteristic of team excellence?
 
  a. Standards of excellence
  b. Clear norms of conduct
  c. Competent team members
  d. Principled leadership



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

helenmarkerine

  • Sr. Member
  • ****
  • Posts: 324
Answer to Question 1

C

Answer to Question 2

C





 

Did you know?

Approximately one in four people diagnosed with diabetes will develop foot problems. Of these, about one-third will require lower extremity amputation.

Did you know?

A cataract is a clouding of the eyes' natural lens. As we age, some clouding of the lens may occur. The first sign of a cataract is usually blurry vision. Although glasses and other visual aids may at first help a person with cataracts, surgery may become inevitable. Cataract surgery is very successful in restoring vision, and it is the most frequently performed surgery in the United States.

Did you know?

On average, someone in the United States has a stroke about every 40 seconds. This is about 795,000 people per year.

Did you know?

It is widely believed that giving a daily oral dose of aspirin to heart attack patients improves their chances of survival because the aspirin blocks the formation of new blood clots.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library